FDA, Novo and Shortage
American demand for weight-loss drugs is supercharging Denmark’s economy and transforming a small Danish community into an ...
A new survey has shown which companies in Denmark are trusted the most and least. Novo Nordisk is at the top, followed by ...
Novo Nordisk thrives despite competition and explore its breakthrough amycretin study. Read here to know why we rate NVO ...
Pharmaceutical giant Novo Nordisk (NYSE: NVO) released its fourth-quarter and full-year earnings report on Feb. 5. The ...
Having examined the options trading patterns of Novo Nordisk, our attention now turns directly to the company. This shift ...
Novo Nordisk is seeking up to US$830 million in damages from KBP Biosciences, according to a ruling by a Singapore court, as ...
Novo Nordisk reprimanded for allegedly failing to disclose payments - The manufacturer of the weight loss jab Wegovy said it ...
Novo Nordisk is growing its India-based global business services to fill out vertical stacks, expand horizontal functions, ...
Novo Nordisk, the Danish pharmaceutical giant, has filed a lawsuit against Singapore-based KBP Biosciences and its founder, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results